$PFE Recent News Here’s what history says about the

New Post Public Reply Private Reply Replies (0) Message Board

Aug 30, 2014 at 12:32 PM

$PFE Recent News

Here’s what history says about the stock market in September 1:15 p.m. Aug. 29, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com

Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - August Update 11:49 p.m. Aug. 29, 2014 - Seeking Alpha
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog 6:10 p.m. Aug. 29, 2014 - Zacks.com
BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog 5:20 p.m. Aug. 29, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Is GlaxoSmithKline A Solid Long-Term Investment? 1:46 p.m. Aug. 29, 2014 - Seeking Alpha
European Stocks See Tentative Rise 12:37 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
There's No Need for Investors to Fear September 12:18 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
Dow 30 Stock Roundup: UTX Reiterates Guidance, BA Wins $8.8B Order - Analyst Blog 11:16 a.m. Aug. 29, 2014 - Zacks.com
FDA clears generic Dacogen 10:29 a.m. Aug. 29, 2014 - Seeking Alpha
Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Top 10 Dow Dividend Stocks for August 3:50 a.m. Aug. 29, 2014 - InvestorPlace.com
I Am Sure This Pharma-Company Suits Your Portfolio 12:52 p.m. Aug. 28, 2014 - GuruFocus.com
Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures 11:21 a.m. Aug. 28, 2014 - GuruFocus.com
Pfizer Vaccine Candidate Gets Fast Track 8:45 a.m. Aug. 28, 2014 - The Wall Street Journal Interactive Edition
Fed Chief Yellen Still a Multimillionaire 12:01 a.m. Aug. 28, 2014 - The Wall Street Journal Interactive Edition
Growth Prospects Remain Strong For Pfizer 3:44 p.m. Aug. 27, 2014 - Seeking Alpha
Short Interest Swings in High-Yield Dividend Stocks 12:29 p.m. Aug. 27, 2014 - 247WallSt.com
Will Pfizer Take One Last Swing at AstraZeneca? 6:45 a.m. Aug. 27, 2014 - InvestorPlace.com
Despite Multiple Headwinds, Pfizer Stock Is Worth a Long Look 8:41 a.m. Aug. 26, 2014 - InvestorPlace.com

InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Global Diabetic Neuropathy Market 2014-2018 12:48 p.m. Aug. 28, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation 8:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard 9:10 a.m. Aug. 27, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 3:23 p.m. Aug. 26, 2014 - PR Newswire - PRF
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen 8:01 a.m. Aug. 26, 2014 - BusinessWire - BZX
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014 2:44 p.m. Aug. 25, 2014 - PR Newswire - PRF
Arteriosclerosis Global Clinical Trials Review, H2, 2014 2:41 p.m. Aug. 25, 2014 - PR Newswire - PRF
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 2:38 p.m. Aug. 25, 2014 - PR Newswire - PRF
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Premier Biotechnology & Anti-CTLA4 8:02 a.m. Aug. 18, 2014 - ACCESSWIRE
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA 8:00 a.m. Aug. 18, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Summit Midstream Prepares for Q3 2026 Earnings Report

Quarterly financials are the canary in the coal mine for any energy firm. Scrutinizing those numbers can be the difference between riding a bull market or nursing your wounds in a ditch. So, what's on tap for Summit Midstream Corporation (NYSE: SMC)? They've circled November 9, 2026, on the calendar for releasing their third quarter figures, just after the NYSE bell...

Doughy Reinvents Cookie Dough with Bold New Identity

A Gourmet Transformation: Doughy's New Identity Cookie dough isn't just for sneaking off a spoon anymore, or at least that's what Doughy aims to redefine with its innovative new identity. Launched from Kelly Ramey's brainchild in her Santa Monica kitchen, Doughy's journey from a homemade recipe to a retail sensation is nothing short of remarkable. Love it or hate it, this...

Ally Financial Scores High Marks: Banking and Workplace

Ally's Impressive Award Sweep Takes the Spotlight There's something palpable about consistently being on top of the game in a sector as cutthroat as banking. Ally Financial is turning heads with a series of recognitions that paint a picture of a company doing more than just crunching numbers under the ticker NYSE:ALLY. Why Ally Bank Tops the Banking Charts Ally's been...

Martin's Holiday Heatwave: Mixing Summer Flavors

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

ON1 Photo RAW 2027: New AI Tools, Better Processing

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

ADIPEC 2026: Energy and AI Steal the Spotlight

Unveiling the Future at ADIPEC 2026 ADIPEC 2026 kicked off with the kind of fanfare you'd expect only from a heavyweight gathering at the intersection of energy, AI, and investment strategy. Dr. Sultan Al Jaber and Sam Altman, two bigwigs in their fields, stood front and center to point out the latest priorities shaping these industries. And let me tell you, it's a wild...

Academy Sports Teams Up With Little Debbie for Holidays

Collaboration Brews Between Academy and Little Debbie Holiday cheer isn't complete without a mash-up that gets tongues wagging and wallets opening. Only this time, a sporting goods giant and your favorite snack cake brand are bringing us the yuletide spirit. Academy Sports + Outdoors has teamed up with Little Debbie for a limited-time collaboration under its Magellan...

Gutiérrez Honored with Enrique V. Iglesias Award

Gutiérrez Recognized for Civic and Business Impact Alright, folks, here's a scenario to chew on: Dionisio Gutiérrez, a name that's likely resonated in business and civic corridors for a while, is about to add another feather to his cap. This November 4, Gutiérrez will bask in the limelight as King Felipe VI of Spain hands him the 11th Enrique V. Iglesias Award. It's...

TalentNeuron Enhances Workforce Planning with New Tools

A Game Changer for Workforce Strategy You ever get the feeling businesses treat workforce planning like a jigsaw puzzle, except the pieces change shape daily? Well, TalentNeuron's out here flipping the table by introducing some fancy new capabilities that'll make those pieces fit a whole lot easier. Yeah, it's about time someone thought to merge continuous workforce...

Windward Expands Maritime Scope with Azimut.ai Deal

An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...